Elite Pharmaceuticals Files Q1 FY2027 Results, Schedules Aug 14 Call

What Happened
Elite Pharmaceuticals, Inc. (ELTP) filed its quarterly report on Form 10-Q for the first quarter ended June 30, 2026 (fiscal 2027) and issued a press release announcing its quarterly financial results. The press release is furnished as Exhibit 99.1 to the 8-K. The company will host a conference call at 11:30 AM Eastern Daylight Time on Friday, August 14, 2026, to provide a general business update and will respond to shareholder questions submitted in advance.

Key Details

• Filed Form 10-Q for the quarter ended June 30, 2026 and furnished a results press release (Exhibit 99.1).
• Conference call: August 14, 2026 at 11:30 AM EDT. Dial-ins: 1-800-346-7359 (domestic), 1-973-528-0008 (international); conference number 98840.
• Submit questions (financial questions by 7:00 PM EDT on Aug 13, 2026) to dianne@elitepharma.com; company will address pre-submitted shareholder questions.
• Audio replay available at: https://elite.irpass.com/events_presentations. The disclosure was furnished under Item 7.01 (Regulation FD); per Item 9.01 the furnished materials are not “filed” for Section 18 liability or automatic incorporation by reference.

Why It Matters
This 8-K signals that up-to-date quarterly financials and a management update are available—important for investors monitoring Elite’s recent performance and near-term outlook. The scheduled call and Q&A give shareholders direct access to management commentary; the Form 10-Q contains the detailed financial results and disclosures investors should review before making decisions. Note the company treated the press release and related disclosures as furnished (not filed), which affects certain legal liabilities and incorporation by reference.